Nov 09, 2021 / 03:30PM GMT
Judah C. Frommer - Crédit Suisse AG - Research Division - Senior Analyst
Welcome, everyone, to the 2021 Credit Suisse Healthcare Conference. I'm Judah Frommer, senior biotech analyst here at CS. And we're thrilled to have Will Lewis, Chair and CEO from Insmed, here with us.
I'll just remind the audience, if you do have any questions you'd like to ask Will, you can certainly e-mail those over to me, [email protected].
Questions and Answers:
Judah C. Frommer - Crédit Suisse AG - Research Division - Senior AnalystAnd with that, let's jump in. Will, you've outlined the framework of 4 strategic pillars for the company. So maybe to better understand the Insmed story, can you walk us through those pillars before we delve deeper into each one?
William H. Lewis - Insmed Incorporated - President, CEO & Chairman
Sure. And I have to say, to start out, we are in a fantastic position as a company. I mean I think we have centered around these 4
Trustpilot
